Skip to main content
TipRanks
Go Ultimate75% OFF

Sunshine Biopharma (SBFM) Q2 2022 Earnings Report

494 Followers

SBFM Q2 2022 EPS Results

Actual EPS
-$680.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$24,080.00

SBFM Q2 2022 Revenue Results

Actual Revenue
$150.31K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2022
Date
08/03/2022
Time
After Close
Conference Call
Wednesday, August 3, 2022
SBFM Upcoming Earnings

Sunshine Biopharma's next earnings date is estimated for May 20, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

SBFM Earnings History

SBFM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 20, 20272027 (Q1)―--0.25――
Nov 10, 20262026 (Q3)-3.40-5.20-3886.31% (+32.80)
Aug 05, 20262026 (Q2)-1.20-1.15-3.970.51% (+2.75)
May 14, 20262026 (Q1)-32.00-50.00-8843.18% (+38.00)
Nov 11, 20252025 (Q3)-1.30-1.90-9.479.79% (+7.50)
Jul 30, 20252025 (Q2)-0.11-0.39-9.9496.04% (+9.55)
May 15, 20252025 (Q1)―-88.00-800098.90% (+7912.00)
Apr 08, 20252024 (Q4)0.01-0.84-4097.91% (+39.16)
Nov 06, 20242024 (Q3)―-188.00-1600098.83% (+15812.00)
Aug 19, 20242024 (Q2)-120.00-1988.00-800075.15% (+6012.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed